|
|
|
|
|
OVARIAN CLUB The Oocyte: from Basic Research to Clinical Practice The forum that will spearhead the field of reproduction for the future
Princesa Sofia Hotel, Barcelona, Spain, November 3-6, 2011 |
|
|
| Scientific Program |
 |
|
|
| Thursday, November 3, 2011 |
Social Club Meet & Greet at the Princesa Sofia Hotel from 19:00-20:00 __________________________________________________________
Program still subject to change, please continue to check for updates!
|
09:00-10:30 |
SESSION 1: OOCYTE BIOLOGY |
|
|
Chairpersons: R. Fleming, UK; Zeev Shoham, Israel; Alex Tsafriri, Israel |
|
09:00-09:30 |
Oocyte regeneration during adult life: Basic information and clinical implications N. Dekel, Israel |
|
09:30-10:00 |
The symphony between the oocyte and the follicle cells J. Richards, USA |
|
10:00-10:30 |
Oocytes under arrest! A “Whodunit” J. Eppig, USA |
|
10:30-11:00 |
Coffee Break |
|
11:00-13:00 |
SESSION 2: METABOLISM AND NUTRITION OF THE OOCYTE |
|
Chairpersons: D. Albertini, USA; S. Fishel, UK |
|
11:00-11:30 |
Mitochondrial and redox metabolism of the mammalian oocyte: The role of glucose, lactate and pyruvate R. Dumollard, France |
|
11:30-12:00 |
Oocyte energy metabolism and embryo developmental competence R. Sturmey, UK |
|
12:00-12:30 |
Rate of energy sensors in the different ovarian function J. Dupont, France |
|
12:30-13:00 |
|
|
13:00-13:45 |
Lunch Break |
|
13:45-14:15 |
|
NEW HORIZONS: THE VOICE OF THE INDUSTRY Company symposium sponsored by IBSA Chairperson: B. Fauser, The Netherlands |
|
The FSH drug products: A comparative study of their glycosylation profile Dr. Paolo Caccia Director of the Protein Purification and Characterization Department, IBSA. Lugano, Switzerland | |
|
14:15-15:45 |
SESSION 3: THE GENOME AND THE OOCYTE |
|
Chairperson: N. Dekel, Israel; A. Pellicer, Spain; A. Veiga, Spain |
|
14:15-14:45 |
Genetic issue related to the oocyte; The FMR1 gene N. Gleicher , USA |
|
14:45-15:15 |
Oocyte genomic integrity: A constitutive DNA damage repair response D. Albertini , USA |
|
15:15-15:45 |
Differences in genetic integrity and metabolism of oocytes from normal and polycystic ovaries A. Balen, UK |
|
15:45-16:15 |
Coffee Break |
|
16:15-18:15 |
SESSION 4: DRUGS USED FOR STIMULATION AND THE OOCYTE |
|
Chairpersons: S. Mashiach, Israel; P.C. Wong, Singapore |
|
16:15-16:35 |
How to render gonadotropin ovarian stimulation more patient-tailored, and why is this relevant? B. Fauser, The Netherlands |
|
16:35-16:55 |
Rejuvenating ovarian function: DHEA? (Improves IVF outcomes, and reduces aneuploidy) N. Gleicher, USA |
|
16:55-17:15 |
FSH, LH, hCG and oocyte quality J. Smitz, Belgium |
|
17:15-17:35 |
The effect of FSH isoforms on the gene expression of cumulus cells and pregnancy rates T. Gürgan, Turkey |
|
17:35-17:55 |
Use of growth hormone in ovarian stimulation protocols P. Barri, Spain |
|
17:55-18:15 |
Q&A |
|
|
| Social Club Meet & Greet at the Princesa Sofia Hotel from 18:00-19:00 |
| Saturday, November 5, 2011 |
|
09:00-10:30 |
SESSION 5: IN-VITRO MATURATION OF THE OOCYTE |
|
Chairpersons: A. Balen, UK; A. Ellenbogen, Israel; R. Fleming, UK |
|
09:00-09:30 |
Oocyte maturation and mitochondrial distribution during human IVM Y. Morimoto, Japan |
|
09:30-10:00 |
Physiology and practical implication in IVM R. Ron-El, Israel |
|
10:00-10:30 |
|
|
10:30-11:00 |
Coffee Break |
|
11:00-13:00 |
SESSION 6: THE OOCYTE AND FERTILITY PRESERVATION |
|
Chairpersons: P. Crosignani, Italy; Y. Morimoto, Japan; J. Smitz, Belgium |
|
11:00-11:30 |
Fresh and frozen ovary transplant results: A robust technique S. Silber, USA |
|
11:30-12:00 |
The oocyte: Chemotherapy and radiation – damage and prevention of it D. Meirow, Israel |
|
12:00-12:30 |
Freeze preservation of ovarian cortex tissue for future pre-production C.Y. Andersen, Denmark |
|
12:30-13:00 |
Oocyte cryopreservation: Slow freezing vs. vitrification A. Veiga, Spain |
|
13:00-13:45 |
Lunch Break |
|
13:45-14:15 |
|
NEW HORIZONS: THE VOICE OF THE INDUSTRY Company symposium sponsored by Ferring
Chairperson: Z. Shoham, Israel |
|
Gonadatrophin stimulation in ART: Past, present and future Professor Julian Jenkins, D.M, F.R.C.O.G. Senior Medical Director Head of Global Medical Affairs Ferring International Center SA St. Prex, Switzerland | |
| 14:15-15:45 |
SESSION 7: LOOKING AT THE OOCYTE QUALITY |
|
Chairpersons: J. Eppig, USA; D. Meirow, Israel; J. Richards, USA |
|
14:15-14:35 |
The relationship between ovarian reserve, oocyte yield, and egg quality S. Nelson, UK |
|
14:35-14:55 |
Cumulus cells and oocyte competence S. Hamamah, France |
|
14:55-15:15 |
Non invasive markers evaluating oocytes quality M.J. de los Santos, Spain |
|
15:15-15:35 |
Oocyte quality and lifestyle choices P. Crosignani, Italy |
| 15:35-15:45 |
Q&A |
|
15:45-16:15 |
Coffee Break |
|
16:15-18:15 |
SESSION 8: OVARIAN AGING: ASSESSMENT, IMPLICATIONS AND NEW TECHNOLOGIES |
|
Chairperson: B. Fauser, The Netherlands; N. Gleicher, USA; G. Schatten, USA |
|
16:15-16:45 |
|
|
16:45-17:15 |
|
|
17:15-17:45 |
New Technologies:
|
|
17:45-18:15 |
Nuclear transfer P. Loi, Italy |
|
09:00-10:30 |
SESSION 9: OOCYTE COMPETENCE |
|
Chairpersons: U. Eichenlaub-Ritter, Germany: S. Hamamah, France |
|
09:00-09:20 |
The role of the oolemma in the transition from fertilization to embryo developmental competence: Possible explanations for fertilization failure and preimplantation arrest J. Van Blerkom, USA |
|
09:20-09:40 |
Is predicting oocyte competence by polar body 23 paired chromosome analysis useful in IVF? S. Fishel, UK |
|
09:40-10:00 |
Are PCO oocytes "inferior"? G. Kovacs, Australia |
|
10:00-10:20 |
Initiation of follicle development in the mammalian ovary and in disordered follicular development in PCOS S. Franks, UK |
|
10:30-11:00 |
Coffee Break |
|
11:00-13:00 |
SESSION 10: CRYOBIOLOGY |
|
Chairpersons: B. Fauser, The Netherlands; T. Gürgan, Turkey; D. Meirow, Israel |
|
11:00-11:20 |
Stress and the oocyte: Oxidative, heat and chilling A. Arav, Israel |
|
11:20-11:40 |
Freeze dried oocytes and "micro-cytoplast" P. Loi, Italy |
|
11:40-12:00 |
Oocyte banking: Storage problem - possible cross contamination and safety?
A. Cobo, Spain |
|
12:00-12:30 |
|
|
12:00-12:15 |
S. Silber, USA |
|
12:15-12:30 |
C.Y. Andersen, Denmark |
|
12:30-13:00 |
Q&A |
|
|
|
|
|